ChineseInvestors.com, Inc. (CIIX) Readies Spin Off of CBD Biotech Co. Ltd. Subsidiary and Retains Underwriter for IPO
CIIX recently hired Boustead Securities LLC as underwriter for the planned IPO of its wholly owned subsidiary, CBD Biotech Warren Wang, CEO of CIIX, said that the move is part of its strategic plan, as CIIX looks to return to its root activities in education and consulting with companies seeking to raise profile within the investment community Boustead Securities would serve as IPO sponsor and underwriter, CIIX said ChineseInvestors.com, Inc.’s (OTCQB: CIIX) retention of Boustead Securities LLC for its anticipated IPO of wholly owned foreign enterprise CBD Biotech will enable the company to focus on its revenue base in video…